(Q36291835)

English

Allelic imbalance at chromosome 17p13.3 (YNZ22) in breast cancer is independent of p53 mutation or p53 overexpression and is associated with poor prognosis at medium-term follow-up

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Allelic imbalance at chromosome 17p13.3 (YNZ22) in breast cancer is independent of p53 mutation or p53 overexpression and is associated with poor prognosis at medium-term follow-up (English)

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

1 reference

based on heuristic

inferred from title

author name string

Thompson AM

1

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Crichton DN

2

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Elton RA

3

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Clay MF

4

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Chetty U

5

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Steel CM

6

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

language of work or name

0 references

publication date

1 March 1998

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

British Journal of Cancer

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

77

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

5

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

797-800

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

https://scigraph.springernature.com/pub.10.1038/bjc.1998.129

0 references

Mutation of the TP53 gene and allelic imbalance at chromosome 17p13 in ductal carcinoma in situ

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149971

30 September 2017

High levels of loss at the 17p telomere suggest the close proximity of a tumour suppressor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149971

30 September 2017

Prognostic significance of TP53 alterations in breast carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149971

30 September 2017

The p53 tumor suppressor gene in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149971

30 September 2017

Oncogene protein co-expression. Value of Ha-ras, c-myc, c-fos, and p53 as prognostic discriminants for breast carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149971

30 September 2017

Prognostic significance of p53 overexpression in primary breast cancer; a novel luminometric immunoassay applicable on steroid receptor cytosols

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149971

30 September 2017

p53 as a prognostic factor in stage I breast cancer. South-East Sweden Breast Cancer Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149971

30 September 2017

p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149971

30 September 2017

Atypical ductal hyperplasia of the breast: clonal proliferation with loss of heterozygosity on chromosomes 16q and 17p.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149971

30 September 2017

ABR, an active BCR-related gene

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149971

30 September 2017

Evidence that p53 behaves as a tumour suppressor gene in sporadic breast tumours

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149971

30 September 2017

p53 gene mRNA expression and chromosome 17p allele loss in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149971

30 September 2017

Mutations in p53 as potential molecular markers for human breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149971

30 September 2017

Loss of heterozygosity on chromosome 17p13 in breast carcinomas identifies tumors with high proliferation index

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149971

30 September 2017

Loss of heterozygosity on the short arm of chromosome 17 is associated with high proliferative capacity and DNA aneuploidy in primary human breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149971

30 September 2017

p53 protein expression in human breast carcinoma: relationship to expression of epidermal growth factor receptor, c-erbB-2 protein overexpression, and oestrogen receptor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149971

30 September 2017

Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149971

30 September 2017

Technical approach for the study of the genetic evolution of breast cancer from paraffin-embedded tissue sections.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149971

29 June 2018

Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149971

29 June 2018

Association of genetic alterations on chromosome 17 and loss of hormone receptors in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149971

29 June 2018

Evidence implicating at least two genes on chromosome 17p in breast carcinogenesis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149971

29 June 2018

Direct sequencing from touch preparations of human carcinomas: analysis of p53 mutations in breast carcinomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149971

29 June 2018

p53 allele losses, mutations and expression in breast cancer and their relationship to clinico-pathological parameters

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149971

29 June 2018

Nuclear p53 Immunoreaction Associated with Poor Prognosis of Breast Cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149971

29 June 2018

TP53 mutations and breast cancer prognosis: particularly poor survival rates for cases with mutations in the zinc-binding domains.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149971

22 September 2018

p53 mutations and c-erbB-2 amplification in intraductal and invasive breast carcinomas of high histologic grade.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149971

22 September 2018

Correlation of loss of alleles on the short arms of chromosomes 11 and 17 with metastasis of primary breast cancer to lymph nodes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149971

22 September 2018

Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/9514060

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human breast cancer: frequent p53 allele loss and protein overexpression

1 reference

https://pubmed.ncbi.nlm.nih.gov/9514060

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Somatic p53 mutations in human breast carcinomas in an Icelandic population: a prognostic factor

1 reference

https://pubmed.ncbi.nlm.nih.gov/9514060

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunohistochemical detection of p53 protein in mammary carcinoma: an important new independent indicator of prognosis?

1 reference

https://pubmed.ncbi.nlm.nih.gov/9514060

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

p53 as an independent prognostic marker in lymph node-negative breast cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/9514060

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allelic loss on a chromosome 17 in ductal carcinoma in situ of the breast

1 reference

https://pubmed.ncbi.nlm.nih.gov/9514060

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship between p53 expression and other prognostic factors in human breast carcinoma. An immunohistochemical study

1 reference

https://pubmed.ncbi.nlm.nih.gov/9514060

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Overexpression of p53 and prognosis in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/9514060

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Overexpression of p53 and HER-2/neu proteins as prognostic markers in early stage breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/9514060

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

p53 protein accumulation detected by five different antibodies: relationship to prognosis and heat shock protein 70 in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/9514060

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Genetic studies of 457 breast cancers. Clinicopathologic parameters compared with genetic alterations

1 reference

https://pubmed.ncbi.nlm.nih.gov/9514060

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Validation of p53 accumulation as a predictor of distant metastasis at 10 years of follow-up in 1400 node-negative breast cancers

1 reference

https://pubmed.ncbi.nlm.nih.gov/9514060

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

P53 expression in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/9514060

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allele loss on short arm of chromosome 17 in breast cancers

1 reference

https://pubmed.ncbi.nlm.nih.gov/9514060

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

At least four different chromosomal regions are involved in loss of heterozygosity in human breast carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/9514060

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Loss of chromosome 17p13 sequences and mutation of p53 in human breast carcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/9514060

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relation between p53 overexpression and established prognostic factors in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/9514060

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mutations in the p53 gene in primary human breast cancers

1 reference

https://pubmed.ncbi.nlm.nih.gov/9514060

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Spatial organization of ABR and CRK genes on human chromosome band 17p13.3.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9514060

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Accumulation of p53 protein as a possible predictor of response to adjuvant combination chemotherapy with cyclophosphamide, methotrexate, fluorouracil, and prednisone for breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/9514060

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Five distinct deleted regions on chromosome 17 defining different subsets of human primary breast tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/9514060

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/9514060

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic value of p53 in breast invasive ductal carcinoma: an immunohistochemical study on 942 cases

1 reference

https://pubmed.ncbi.nlm.nih.gov/9514060

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detailed mapping and loss of heterozygosity analysis suggests a suppressor locus involved in sporadic breast cancer within a distal region of chromosome band 17p13.3.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9514060

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/9514060

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An immunochemical analysis of the human nuclear phosphoprotein p53. New monoclonal antibodies and epitope mapping using recombinant p53

1 reference

https://pubmed.ncbi.nlm.nih.gov/9514060

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/BJC.1998.129

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36291835&oldid=1519712057"